Metraipolis › archive › dc_2f1c596f33b5

All-Oral PI3Kδ and HDAC Inhibition with Parsaclisib Plus Chidamide and Step-Down Maintenance in Relapsed or Refractory Peripheral T-Cell Lymphoma: A Phase Ib… — Europe PMC PMID:42827632

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42827632
DOI
10.1002/mco2.70993
License (as archived)
solo-consultazione
Archived
2026-10-07T14:32:27.069Z
SHA-256 of the archived text
5b497b51c5d058c710bf541dda95102e212e26dd177e720caf2f3b1f941ed1bd
Stable URL of this page
https://metraipolis.com/documento/dc_2f1c596f33b5

How to cite

All-Oral PI3Kδ and HDAC Inhibition with Parsaclisib Plus Chidamide and Step-Down Maintenance in Relapsed or Refractory Peripheral T-Cell Lymphoma: A Phase Ib… — Europe PMC PMID:42827632 — Europe PMC (en), https://europepmc.org/article/MED/42827632 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f1c596f33b5 (Metraipolis archive dc_2f1c596f33b5, sha256 5b497b51c5d058c710bf541dda95102e212e26dd177e720caf2f3b1f941ed1bd)
BibTeX
@misc{dc2f1c596f33b5,
  title = {All-Oral PI3Kδ and HDAC Inhibition with Parsaclisib Plus Chidamide and Step-Down Maintenance in Relapsed or Refractory Peripheral T-Cell Lymphoma: A Phase Ib… — Europe PMC PMID:42827632},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42827632},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f1c596f33b5; sha256 5b497b51c5d058c710bf541dda95102e212e26dd177e720caf2f3b1f941ed1bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42827632. Agents can read the archived copy with the MCP tool read_document.